Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
TMS Issues Letter to Shareholders: 2025 Year-in-Review and Strategic Outlook for 2026
Non-consolidated Financial Results for the Six Months Ended August 31, 2025 [Japanese GAAP]
Presentation Material for the Six Months Ended August 31, 2025
Notice of Initiation of Analyst Coverage by Pathology Associates
Non-consolidated Financial Results for the Three Months Ended May 31, 2025 [Japanese GAAP]
Notice of Administration of TMS-007 (JX10) to the First Subject in the ORION (Phase II/III) Clinical Trial
TMS submits CTN for Phase II/III ORION Study Japan Cohort of JX10 to PMDA
Non-consolidated Financial Results for the Fiscal Year Ended February 28, 2025 [Japanese GAAP]
Presentation Material for the Fiscal Year Ended February 28,2025
Notice of TMS-008 Phase I First Data Readout
Notice Regarding the Exercise Price Payment of the 10th Share Acquisition Rights (with Moving Strike Warrant) by Third-Party Allotment
[Delayed]Notice Regarding the Issuance of the 10th Series of Stock Acquisition Rights (with Moving Strike Warrant) by Third-Party Allotment
Notice of Royalty and Compensation Payment
Notice of Change in Fiscal Year End (Financial Year End)
TMS Co., Ltd. Entered into a Joint Research Agreement with Tokushima University
[Delayed]Notice on the Status of JX10 (TMS-007) Clinical Trial Application in China
Announcement of presentation on TMS-007(JX10) at International Stroke Conference (ISC) 2025
Non-consolidated Financial Results for the Nine Months Ended November 30, 2024 [Japanese GAAP]
TMS to Host an Executive Roundtable at WuXi Global Forum 2025 in San Francisco
TMS Issues Letter to Shareholders Highlighting 2024 Accomplishments and Anticipated Milestones for 2025